Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders
Clinical trial NCT03123458 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03123458
- Sponsor
- Shenzhen Geno-Immune Medical Institute
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2028-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.